Reading Time: 4 minutes There’s no escaping the fact that discovering, developing and testing new drugs costs a lot of money
Author: Steven Globerman
Steven Globerman is Resident Scholar and Addington Chair in Measurement at the Fraser Institute as well as Professor Emeritus at Western Washington University. Previously, he held tenured appointments at Simon Fraser University and York University and has been a visiting professor at the University of California, University of British Columbia, Stockholm School of Economics, Copenhagen School of Business, and the Helsinki School of Economics.
Despite government subsidies, Canadian innovation wanes
Reading Time: 3 minutes Burdensome regulation, limited competition and unfavourable taxes hold Canadian companies back
Canada’s free ride on U.S. drug development may end soon
Reading Time: 3 minutes A shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development
Wake up Canada, you have a business investment crisis
Reading Time: 3 minutes There’s been no growth in years in the corporate assets that help make companies more efficient and profitable
The Canadian economy is at the precipice
Reading Time: 3 minutes From uncertain trade talks to lack of affordable housing to rising interest rates to government debt, the warning signs are rising
Canada’s trade hurdle is all about supply management
Reading Time: 3 minutes The federal government has not explicitly stated that supply management is non-negotiable
Protectionism on the rise as NAFTA talks stall
Reading Time: 3 minutes Against the backdrop of an increasingly fraught political relationship between the U.S. and Mexico, what should Canada do?
Stemming the demographic tide on entrepreneurship in the U.K.
Reading Time: 3 minutes Providing tax relief, eliminating red tape and building entrepreneurial skills will help business startups
Stemming the demographic tide on U.S. entrepreneurship
Reading Time: 4 minutes Policy levers exist that can improve entrepreneurial incentives and increase the chances of successful new business startups
How to spur entrepreneurship in an aging population
Reading Time: 4 minutes Policy levers can strengthen incentives for entrepreneurship and improve the likelihood of successful new business startups